Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment

X Sun, Q Yu - Acta Pharmacologica Sinica, 2015 - nature.com
Recent studies have revealed extensive genetic and non-genetic variation across different
geographical regions of a tumor or throughout different stages of tumor progression, which is …

Targeting oncogenic Ras signaling in hematologic malignancies

AF Ward, BS Braun, KM Shannon - Blood, The Journal of the …, 2012 - ashpublications.org
Ras proteins are critical nodes in cellular signaling that integrate inputs from activated cell
surface receptors and other stimuli to modulate cell fate through a complex network of …

Genomic and evolutionary classification of lung cancer in never smokers

T Zhang, P Joubert, N Ansari-Pour, W Zhao… - Nature …, 2021 - nature.com
Lung cancer in never smokers (LCINS) is a common cause of cancer mortality but its
genomic landscape is poorly characterized. Here high-coverage whole-genome sequencing …

Mouse models of human AML accurately predict chemotherapy response

J Zuber, I Radtke, TS Pardee, Z Zhao… - Genes & …, 2009 - genesdev.cshlp.org
The genetic heterogeneity of cancer influences the trajectory of tumor progression and may
underlie clinical variation in therapy response. To model such heterogeneity, we produced …

Ras/Raf/MEK/ERK pathway activation in childhood acute lymphoblastic leukemia and its therapeutic targeting

T Knight, JAE Irving - Frontiers in oncology, 2014 - frontiersin.org
Deregulation of the Ras/Raf/MEK/extracellular signal-regulated kinase pathway is a
common event in childhood acute lymphoblastic leukemia and is caused by point mutation …

High-content single-cell drug screening with phosphospecific flow cytometry

PO Krutzik, JM Crane, MR Clutter, GP Nolan - Nature chemical biology, 2008 - nature.com
Drug screening is often limited to cell-free assays involving purified enzymes, but it is
arguably best applied against systems that represent disease states or complex …

Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates

N Kotecha, NJ Flores, JM Irish, EF Simonds, DS Sakai… - Cancer cell, 2008 - cell.com
Progress in understanding the molecular pathogenesis of human myeloproliferative
disorders (MPDs) has led to guidelines incorporating genetic assays with histopathology …

p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewal

Z Zhao, J Zuber, E Diaz-Flores, L Lintault… - Genes & …, 2010 - genesdev.cshlp.org
The p53 tumor suppressor limits proliferation in response to cellular stress through several
mechanisms. Here, we test whether the recently described ability of p53 to limit stem cell self …

An ERK-dependent feedback mechanism prevents hematopoietic stem cell exhaustion

C Baumgartner, S Toifl, M Farlik, F Halbritter… - Cell stem cell, 2018 - cell.com
Hematopoietic stem cells (HSCs) sustain hematopoiesis throughout life. HSCs exit
dormancy to restore hemostasis in response to stressful events, such as acute blood loss …

Targeting Ras-, Rho-, and Rab-family GTPases via a conserved cryptic pocket

J Morstein, V Bowcut, M Fernando, Y Yang, L Zhu… - Cell, 2024 - cell.com
The family of Ras-like GTPases consists of over 150 different members, regulated by an
even larger number of guanine exchange factors (GEFs) and GTPase-activating proteins …